JP Stock MarketDetailed Quotes

4896 K Pharma

Watchlist
  • 743
  • 00.00%
20min DelayMarket to Open May 8 15:30 JST
8.62BMarket Cap-10.19P/E (Static)

K Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
1B
0
0
0
0
Cost of revenue
0
0
0
90M
0
0
0
Gross profit
0
0
0
910M
0
0
0
Operating expense
53.76%836.35M
192.7M
230.79M
53.75%543.94M
149.78M
135.27M
61.18%353.77M
219.49M
Operating profit
-328.47%-836.35M
-192.7M
-230.79M
203.47%366.06M
-149.78M
-135.27M
-61.18%-353.77M
-219.49M
Net non-operating interest income (expenses)
102.24%265K
0
14K
-118.44%-11.83M
-8.66M
-3.18M
-541,800.00%-5.42M
1K
Non-operating interest income
1,556.25%265K
--0
--14K
128.57%16K
--0
--9K
600.00%7K
--1K
Total other finance cost
----
----
----
118.46%11.85M
--8.66M
----
--5.42M
----
Net investment income
-1.16M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
81.76%-7.86M
-580K
-2.1M
-37.75%-43.11M
-6.52M
0
-225.16%-31.29M
-9.62M
Less:Other special charges
----
----
----
----
----
--0
----
--1.4M
Less:Write off
-81.76%7.86M
--580K
--2.1M
37.75%43.11M
--6.61M
--0
280.42%31.29M
--8.23M
Other non-operating income (expenses)
109.92%996K
-22,211.11%-10.04M
-6.04M
-1,025.00%-45K
-4K
Income before tax
-380.36%-844.1M
-192.48M
-232.87M
177.09%301.08M
-171M
-142.46M
-70.45%-390.53M
-229.12M
Income tax
-94.23%2.35M
578K
579K
2,044.53%40.75M
-33.11M
-25.9M
575.00%1.9M
-400K
Net income
-425.15%-846.45M
-193.06M
-233.45M
166.34%260.33M
-137.88M
-116.56M
-71.58%-392.43M
-228.72M
Net income continuous operations
-425.15%-846.45M
---193.06M
---233.45M
166.34%260.33M
---137.88M
---116.56M
-71.58%-392.43M
---228.72M
Noncontrolling interests
Net income attributable to the company
-425.15%-846.46M
-193.06M
-233.45M
166.34%260.33M
-137.88M
-116.56M
-71.58%-392.43M
-228.72M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-425.15%-846.46M
-193.06M
-233.45M
166.34%260.33M
-137.88M
-116.56M
-71.58%-392.43M
-228.72M
Gross dividend payment
Basic earnings per share
-386.94%-72.94
-16.63
-20.12
160.44%25.42
-14.889
-11.7987
-112.55%-42.0577
-19.787
Diluted earnings per share
-416.17%-72.94
-16.6362
-20.12
154.85%23.07
-14.889
-11.7987
-112.55%-42.0577
-19.787
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0001B0000
Cost of revenue 00090M000
Gross profit 000910M000
Operating expense 53.76%836.35M192.7M230.79M53.75%543.94M149.78M135.27M61.18%353.77M219.49M
Operating profit -328.47%-836.35M-192.7M-230.79M203.47%366.06M-149.78M-135.27M-61.18%-353.77M-219.49M
Net non-operating interest income (expenses) 102.24%265K014K-118.44%-11.83M-8.66M-3.18M-541,800.00%-5.42M1K
Non-operating interest income 1,556.25%265K--0--14K128.57%16K--0--9K600.00%7K--1K
Total other finance cost ------------118.46%11.85M--8.66M------5.42M----
Net investment income -1.16M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 81.76%-7.86M-580K-2.1M-37.75%-43.11M-6.52M0-225.16%-31.29M-9.62M
Less:Other special charges ----------------------0------1.4M
Less:Write off -81.76%7.86M--580K--2.1M37.75%43.11M--6.61M--0280.42%31.29M--8.23M
Other non-operating income (expenses) 109.92%996K-22,211.11%-10.04M-6.04M-1,025.00%-45K-4K
Income before tax -380.36%-844.1M-192.48M-232.87M177.09%301.08M-171M-142.46M-70.45%-390.53M-229.12M
Income tax -94.23%2.35M578K579K2,044.53%40.75M-33.11M-25.9M575.00%1.9M-400K
Net income -425.15%-846.45M-193.06M-233.45M166.34%260.33M-137.88M-116.56M-71.58%-392.43M-228.72M
Net income continuous operations -425.15%-846.45M---193.06M---233.45M166.34%260.33M---137.88M---116.56M-71.58%-392.43M---228.72M
Noncontrolling interests
Net income attributable to the company -425.15%-846.46M-193.06M-233.45M166.34%260.33M-137.88M-116.56M-71.58%-392.43M-228.72M
Preferred stock dividends
Other under preferred stock dividend 00000000
Net income attributable to common stockholders -425.15%-846.46M-193.06M-233.45M166.34%260.33M-137.88M-116.56M-71.58%-392.43M-228.72M
Gross dividend payment
Basic earnings per share -386.94%-72.94-16.63-20.12160.44%25.42-14.889-11.7987-112.55%-42.0577-19.787
Diluted earnings per share -416.17%-72.94-16.6362-20.12154.85%23.07-14.889-11.7987-112.55%-42.0577-19.787
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More